13 24

Cited 0 times in

Role of Biomarkers in Juvenile Idiopathic Arthritis

Authors
 Jong Gyun Ahn 
Citation
 Journal of Rheumatic Diseases, Vol.27(4) : 233-240, 2020-10 
Journal Title
 Journal of Rheumatic Diseases 
ISSN
 2093-940X 
Issue Date
2020-10
Keywords
Juvenile idiopathic arthritis ; Biomarkers ; Outcome measures
Abstract
The aim of this review was to identify the utility of biomarkers used in the diagnosis and the monitoring and treatment of Juvenile idiopathic arthritis (JIA). JIA is a heterogeneous group of diseases characterized by arthritis of unknown etiology that lasts for at least 6 weeks, with onset before the age of 16 years. Unlike adult rheumatoid arthritis, JIA is a heterogeneous arthritis with different subtypes. The diagnosis of JIA is based on clinical evaluation and often involves ruling out other causes of arthritis. Many biomarkers have been studied or are under development to define the classifications of JIA, assess disease activity, predict disease course, treatment response, or the risk of relapse. The diagnostic and prognostic use of biomarkers in JIA could be applied differently depending on diverse subtypes or individuals. To obtain the best clinical outcomes in JIA, it is important to understand the pathophysiology of each JIA subtype and to select and use appropriate biomarkers.
Files in This Item:
T202005981.pdf Download
DOI
10.4078/jrd.2020.27.4.233.
Appears in Collections:
1. College of Medicine (의과대학) > Others (기타) > 1. Journal Papers
Yonsei Authors
Ahn, Jong Gyun(안종균) ORCID logo https://orcid.org/0000-0001-5748-0015
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/181506
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links